Here's Why This Cathie Wood Stock Crashed Wednesday_老虎社区_美港股上老虎

Here's Why This Cathie Wood Stock Crashed Wednesday

Motley Fool2021-10-07

What happened "A colossal scam." According to a Scorpion Capital report released Wednesday, that's a fitting characterization of Ginkgo Bioworks Holdings (NYSE:DNA), a company specializing in ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

bluetick
·2021-10-07
Hi
回复
2
举报

热议股票

7x24

全部

关于我们·老虎社区守则·老虎社区账号管理规范·老虎社区服务协议·老虎社区隐私政策

公司名称：北京至简风宜信息技术有限公司

违法和不良信息投诉：010-5681-3562（工作时间9:30-18:30）

邮箱：service@laohu8.com

营业执照：91110105MA01A4U55R

ICP备：京ICP备18016422号

网安备：京公网安备11010502036490

关注我们

{"i18n":{"language":"zh_CN"},"data":{"share":"https://www.laohu8.com/m/news/2173213910?lang=zh_CN&edition=full","thumbnail":"","is_english":true,"pubTime":"2021-10-07 15:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2173213910","market":"us","top_or_hot":-1,"title":"Here's Why This Cathie Wood Stock Crashed Wednesday","media":"Motley Fool","content":"<div>\n<p>What happened\n\"A colossal scam.\" According to a Scorpion Capital report released Wednesday, that's a fitting characterization of Ginkgo Bioworks Holdings (NYSE:DNA), a company specializing in ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/heres-why-this-cathie-wood-stock-is-crashing-today/\">网页链接</a>\n\n</div>\n","source":"fool_stock","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why This Cathie Wood Stock Crashed Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why This Cathie Wood Stock Crashed Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-07 15:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/06/heres-why-this-cathie-wood-stock-is-crashing-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\n\"A colossal scam.\" According to a Scorpion Capital report released Wednesday, that's a fitting characterization of Ginkgo Bioworks Holdings (NYSE:DNA), a company specializing in ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/heres-why-this-cathie-wood-stock-is-crashing-today/\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ARKK","symbol_name":"ARK Innovation ETF","start_time":0,"source_url":"https://www.fool.com/investing/2021/10/06/heres-why-this-cathie-wood-stock-is-crashing-today/","article_id":"2173213910","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2173213910","pubTimestamp":1633590120,"sourceInfo":{"source_id":"fool_stock","name":"Motley Fool"},"weMediaInfo":null,"summary":"Scorpion Capital is shooting some venom at a new target today.","collect":0,"end_time":0,"defaultTopTitle":"fool.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"ARKK":"ARK Innovation ETF","DNA":"Ginkgo Bioworks Holdings Inc."},"translate_title":"这就是为什么凯西·伍德股票在周三崩溃","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ARKK":0.9,"DNA":0.9},"content_text":"What happened\n\"A colossal scam.\" According to a Scorpion Capital report released Wednesday, that's a fitting characterization of Ginkgo Bioworks Holdings (NYSE:DNA), a company specializing in synthetic biology. The company, which recently went public through a merger with a special purpose acquisition company, is a holding in Cathie Wood's ARK Innovation ETF, but even Wood's seal of approval isn't enough to stave off the bears' reaction to Scorpion Capital's criticism.\nAs of 10:53 a.m. EDT Wednesday, shares of Ginkgo Bioworks have plunged 19.6%.\n\nImage source: Getty Images.\nSo what\nScorpion Capital's cutting presentation of Ginkgo Bioworks is lengthy. In over 170 slides, Scorpion walks investors through an exhaustive review of the company, pleading the case that the company is tantamount to a grift. After conducting interviews with former employees \"who indicated that they had been terminated for refusing to play along with the scheme, and who stated they knew of others pushed out for similar reasons\" in addition to other investigative actions, Scorpion Capital surmises that the company is a \"snake oil salesman\" whose \"business model is based on a dubious shell game.\"\nNow what\nWith Scorpion Capital throwing a kitchen sink's worth of criticism at Ginkgo Bioworks, it's unsurprising that shares are plummeting Wednesday. Although the report may be fodder for the bears, it's critical that shareholders remember that Scorpion Capital, which maintains a short position in the stock, benefits from the stock's demise. Since it has a vested interest in seeing the stock tumble, therefore, shareholders who may be tempted to click the sell button should take a step back, taking Scorpion Capital's criticisms with a grain -- or heaping tablespoon -- of salt.\nInvestors will likely be closely following how Cathie Wood reacts to the report. Should she decide to close her position in the start-up, it may indicate that the critical report be taken more seriously.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":823346788,"gmtCreate":1633590712795,"gmtModify":1633590712795,"author":{"id":"3572923152976476","authorId":"3572923152976476","name":"bluetick","avatar":"https://static.tigerbbs.com/50c834acf65edd5ddbf6823c1b49ba9e","vip":1,"crmLevel":3,"crmLevelSwitch":0,"idStr":"3572923152976476","authorIdStr":"3572923152976476"},"htmlText":"Hi","listText":"Hi","text":"Hi","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/823346788","repostId":2173213910,"repostType":4,"repost":{"id":"2173213910","pubTimestamp":1633590120,"share":"https://www.laohu8.com/m/news/2173213910?lang=&edition=full","pubTime":"2021-10-07 15:02","market":"us","language":"en","title":"Here's Why This Cathie Wood Stock Crashed Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=2173213910","media":"Motley Fool","summary":"Scorpion Capital is shooting some venom at a new target today.","content":"<h3>What happened</h3>\n<p>\"A colossal scam.\" According to a Scorpion Capital report released Wednesday, that's a fitting characterization of <b>Ginkgo Bioworks Holdings</b> (NYSE:DNA), a company specializing in synthetic biology. The company, which recently went public through a merger with a special purpose acquisition company, is a holding in Cathie Wood's <b><a href=\"https://laohu8.com/S/ARKK\">ARK Innovation ETF</a></b>, but even Wood's seal of approval isn't enough to stave off the bears' reaction to Scorpion Capital's criticism.</p>\n<p>As of 10:53 a.m. EDT&nbsp;Wednesday, shares of Ginkgo Bioworks have plunged 19.6%.</p>\n<p><img src=\"https://static.tigerbbs.com/a46c467aabdec97fcae4487b8643135e\" tg-width=\"700\" tg-height=\"466\" referrerpolicy=\"no-referrer\"></p>\n<p>Image source: Getty Images.</p>\n<h3>So what</h3>\n<p>Scorpion Capital's cutting presentation of Ginkgo Bioworks is lengthy. In over 170 slides, Scorpion walks investors through an exhaustive review of the company, pleading the case that the company is tantamount to a grift. After conducting interviews with former employees \"who indicated that they had been terminated for refusing to play along with the scheme, and who stated they knew of others pushed out for similar reasons\" in addition to other investigative actions, Scorpion Capital surmises that the company is a \"snake oil salesman\" whose \"business model is based on a dubious shell game.\"</p>\n<h3>Now what</h3>\n<p>With Scorpion Capital throwing a kitchen sink's worth of criticism at Ginkgo Bioworks, it's unsurprising that shares are plummeting Wednesday. Although the report may be fodder for the bears, it's critical that shareholders remember that Scorpion Capital, which maintains a short position in the stock, benefits from the stock's demise. Since it has a vested interest in seeing the stock tumble, therefore, shareholders who may be tempted to click the sell button should take a step back, taking Scorpion Capital's criticisms with a grain -- or heaping tablespoon -- of salt.</p>\n<p>Investors will likely be closely following how Cathie Wood reacts to the report. Should she decide to close her position in the start-up, it may indicate that the critical report be taken more seriously.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why This Cathie Wood Stock Crashed Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why This Cathie Wood Stock Crashed Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-07 15:02 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/06/heres-why-this-cathie-wood-stock-is-crashing-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\n\"A colossal scam.\" According to a Scorpion Capital report released Wednesday, that's a fitting characterization of Ginkgo Bioworks Holdings (NYSE:DNA), a company specializing in ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/heres-why-this-cathie-wood-stock-is-crashing-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"DNA":"Ginkgo Bioworks Holdings Inc.","ARKK":"ARK Innovation ETF"},"source_url":"https://www.fool.com/investing/2021/10/06/heres-why-this-cathie-wood-stock-is-crashing-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2173213910","content_text":"What happened\n\"A colossal scam.\" According to a Scorpion Capital report released Wednesday, that's a fitting characterization of Ginkgo Bioworks Holdings (NYSE:DNA), a company specializing in synthetic biology. The company, which recently went public through a merger with a special purpose acquisition company, is a holding in Cathie Wood's ARK Innovation ETF, but even Wood's seal of approval isn't enough to stave off the bears' reaction to Scorpion Capital's criticism.\nAs of 10:53 a.m. EDT Wednesday, shares of Ginkgo Bioworks have plunged 19.6%.\n\nImage source: Getty Images.\nSo what\nScorpion Capital's cutting presentation of Ginkgo Bioworks is lengthy. In over 170 slides, Scorpion walks investors through an exhaustive review of the company, pleading the case that the company is tantamount to a grift. After conducting interviews with former employees \"who indicated that they had been terminated for refusing to play along with the scheme, and who stated they knew of others pushed out for similar reasons\" in addition to other investigative actions, Scorpion Capital surmises that the company is a \"snake oil salesman\" whose \"business model is based on a dubious shell game.\"\nNow what\nWith Scorpion Capital throwing a kitchen sink's worth of criticism at Ginkgo Bioworks, it's unsurprising that shares are plummeting Wednesday. Although the report may be fodder for the bears, it's critical that shareholders remember that Scorpion Capital, which maintains a short position in the stock, benefits from the stock's demise. Since it has a vested interest in seeing the stock tumble, therefore, shareholders who may be tempted to click the sell button should take a step back, taking Scorpion Capital's criticisms with a grain -- or heaping tablespoon -- of salt.\nInvestors will likely be closely following how Cathie Wood reacts to the report. Should she decide to close her position in the start-up, it may indicate that the critical report be taken more seriously.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":9,"commentSize":1,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}